DiaCarta is a biotechnology company focused on developing precision diagnostics and molecular tools for personalized medicine.

DiaCarta

Mission Bio specializes in single-cell DNA analysis, providing tools for precision genomics and personalized medicine.

Mission Bio

Quadrants Scientific is a company that focuses on providing innovative solutions for the life sciences industry, including research tools and technologies.

Quadrants Scientific

Synlogic is a biotechnology company developing synthetic biotic medicines for the treatment of metabolic and inflammatory diseases.

Synlogic

Praxis Precision Medicines is focused on developing therapies for central nervous system disorders, including rare pediatric epilepsies and neuropsychiatric disorders.

Praxis Precision Medicines

Atara Biotherapeutics is a biotechnology company specializing in developing off-the-shelf T-cell immunotherapies for cancer, autoimmune, and viral diseases.

Atara Biotherapeutics

Jnana is a biotechnology company focused on developing small molecule therapeutics targeting solute carrier transporters for the treatment of neurological and metabolic disorders.

Jnana

Avilar Therapeutics is a biotechnology company dedicated to developing novel therapies for cancer and autoimmune diseases.

Avilar Therapeutics

Dunad Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of cancer and autoimmune diseases.

Dunad Therapeutics

Matchpoint Therapeutics is a biotechnology company specializing in the development of precision oncology therapies targeting specific genetic alterations in cancer.

Matchpoint Therapeutics

Enlaza Therapeutics is a biotechnology company that specializes in the development of covalent biologic therapeutics, aiming to create a new class of protein-based drugs that can form strong bonds with disease-related targets for improved treatment outcomes.

Enlaza Therapeutics

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 11, 2024 3:11 AM	e61bfa75
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

FRAZ

COM:FRAZIERLS

Enlaza Therapeutics